GATTI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 3.280
AS - Asia 1.137
EU - Europa 883
SA - Sud America 266
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 43
OC - Oceania 2
Totale 5.703
Nazione #
US - Stati Uniti d'America 3.233
SG - Singapore 459
CN - Cina 299
BR - Brasile 224
IT - Italia 211
SE - Svezia 192
HK - Hong Kong 139
RU - Federazione Russa 109
DE - Germania 74
FI - Finlandia 66
GB - Regno Unito 57
VN - Vietnam 57
FR - Francia 54
UA - Ucraina 46
IN - India 43
BD - Bangladesh 32
BE - Belgio 20
CA - Canada 19
TR - Turchia 18
IQ - Iraq 15
MX - Messico 15
AR - Argentina 13
ZA - Sudafrica 13
JP - Giappone 12
CI - Costa d'Avorio 11
CO - Colombia 9
ID - Indonesia 9
MA - Marocco 8
PL - Polonia 8
PK - Pakistan 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
LT - Lituania 6
UZ - Uzbekistan 6
ES - Italia 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
IE - Irlanda 4
JO - Giordania 4
PY - Paraguay 4
AT - Austria 3
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
CR - Costa Rica 3
GE - Georgia 3
NL - Olanda 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
AU - Australia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
LB - Libano 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 5.612
Città #
Ashburn 378
Fairfield 374
Chandler 311
Singapore 255
Woodbridge 214
Seattle 178
San Jose 168
Nyköping 157
Houston 151
Hong Kong 137
Cambridge 121
Ann Arbor 119
Wilmington 105
Jacksonville 104
Milan 95
Beijing 94
New York 83
Nanjing 51
Dallas 41
Lawrence 40
Roxbury 40
Council Bluffs 39
Los Angeles 38
Helsinki 36
Lauterbourg 36
Rome 36
Des Moines 29
Munich 26
Boardman 24
Inglewood 23
Ho Chi Minh City 22
San Diego 21
Santa Clara 21
Brooklyn 20
Brussels 20
São Paulo 18
Columbus 17
Princeton 17
Dearborn 13
The Dalles 12
Tianjin 12
Tokyo 12
Abidjan 11
Denver 11
Hanoi 11
Bari 10
Johannesburg 10
Chicago 9
Pune 9
Shenyang 9
Belo Horizonte 8
Buffalo 8
Changsha 8
Hebei 8
London 8
Orem 8
Paris 8
San Francisco 8
Shanghai 8
Curitiba 7
Moscow 7
Nanchang 7
Naples 7
Warsaw 7
Zhengzhou 7
Ankara 6
Boston 6
Dhaka 6
Washington 6
Atlanta 5
Brasília 5
Dong Ket 5
Figino 5
Fortaleza 5
Frankfurt am Main 5
Grafing 5
Guarulhos 5
Hefei 5
Montreal 5
Mumbai 5
Rio de Janeiro 5
Tashkent 5
Turku 5
Amman 4
Bogotá 4
Bologna 4
Chennai 4
Delhi 4
Dublin 4
Erbil 4
Haiphong 4
Jiaxing 4
Jinan 4
Miami 4
New Delhi 4
Nuremberg 4
Porto Alegre 4
Redwood City 4
Toronto 4
Aci Castello 3
Totale 4.063
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 233
F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus 219
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 206
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C 195
Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: Analysis of complications in a single centre over 20 years 165
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 162
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin 161
Ablative therapies for intrahepatic cholangiocarcinoma 160
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 159
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome 157
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 156
B-cell depletion in the treatment of mixed cryoglobulinemia. 154
Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance 153
Recent patents relating to HCV molecules like putative targets for therapeutic intervention. 152
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 150
Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study 149
Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance 148
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3 147
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 145
Hepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report. 143
Hepatitis C virus infection, lymphoproliferation and non-Hodgkin’s B cell lymphoma 136
High- Powered Microwaves Ablation: An Emerging and Safe Tool for Treatment of Intrahepatic Cholangiocarcinoma 134
Hepatitis C virus infection, mixed crioglobulinemia, and non-Hodgkin’s lymphoma: an emerging picture 132
Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial 129
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 123
18F-FDG PET/CT evaluation in diagnosis and follow-up of patients with hepato-cellular carcinoma 117
Bone metastases in hepatocellular carcinoma: an emerging issue 117
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 116
Hepatitis C virus infection involves CD34+ hematopoietic porgenitor cells in hepatitis C virus chronic carriers. 113
Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy 108
Alcolizzazione percutanea del piccolo HCC. Casistica personale 104
A Giant Gastric Hyperplastic Polyp in Non-Familial Juvenile Polyposis of the Stomach: A Case Report 103
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 102
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 98
Ruolo dell’ecotomografia tiroidea nel follow-up di pazienti affette da carcinoma mammario in trattamento chemioterapico adiuvante con antracicline 91
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 90
Virus C dell’epatite, crioglobulinemia mista e linfomi non-Hodgkin 80
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 76
18F-FDG PET/CT evaluation in diagnosis and follow up of patients with hepato-cellular carcinoma 71
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 67
null 61
null 60
Termoablazione percutanea a radiofrequenza di epatocarcinoma 59
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 55
null 47
Totale 5.703
Categoria #
all - tutte 23.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022297 0 0 11 22 13 37 11 16 19 26 55 87
2022/2023698 82 96 76 72 68 90 4 82 85 4 23 16
2023/2024306 13 39 13 11 32 95 11 55 0 8 3 26
2024/2025800 21 19 62 32 41 76 108 79 30 43 91 198
2025/20261.584 272 70 82 129 190 104 191 42 147 132 70 155
2026/2027167 40 65 62 0 0 0 0 0 0 0 0 0
Totale 5.703